Abstract | OBJECTIVE: METHODS: A retrospective analysis of 17 intractable Ménière's disease patients treated with intratympanic methylprednisolone perfusion was performed. Treatment efficacy was evaluated according to the American Academy of Otolaryngology-Head and Neck Surgery criteria. Short and long-term control or improvement rates were calculated after 6 and 24 months, respectively. RESULTS: Sixteen patients were followed for more than two years. Short- and long-term vertigo control rates were 94 per cent and 81 per cent, respectively; short- and long-term functional activity improvements were 94 per cent and 88 per cent, respectively. The pure tone average was 53 ± 14 dB before treatment, and 50 ± 16 dB at 6 months and 52 ± 20 dB at 24 months after intratympanic methylprednisolone perfusion. Tinnitus was controlled or improved in five patients over the two-year follow-up period. CONCLUSION:
|
Authors | W She, L Lv, X Du, H Li, Y Dai, L Lu, X Ma, F Chen |
Journal | The Journal of laryngology and otology
(J Laryngol Otol)
Vol. 129
Issue 3
Pg. 232-7
(Mar 2015)
ISSN: 1748-5460 [Electronic] England |
PMID | 25655232
(Publication Type: Journal Article)
|
Chemical References |
- Glucocorticoids
- Methylprednisolone
|
Topics |
- Adult
- Audiometry, Pure-Tone
(methods)
- Female
- Glucocorticoids
(administration & dosage, adverse effects)
- Humans
- Injection, Intratympanic
- Male
- Meniere Disease
(drug therapy, physiopathology)
- Methylprednisolone
(administration & dosage, adverse effects)
- Middle Aged
- Retrospective Studies
- Treatment Outcome
|